(Q80439598)
Statements
Weekly docetaxel and bortezomib as first-line treatment for patients with hormone-refractory prostate cancer: a Minnie Pearl Cancer Research Network phase II trial (English)
John D Hainsworth
Anthony A Meluch
David R Spigel
John Barton
Lisa Simons
Christina Meng
Bruce Gould
F Anthony Greco
1 March 2007